Biotech slams study that gave Covishield an advantage, says Covaxin Ph 3 data will be out in July

preview_player
Показать описание
Days after an early study claimed that the Covishield vaccine produces more antibodies against coronavirus infection than Covaxin, the latter's manufacturer on Wednesday came out with a statement and said that the preliminary research has "a lot of flaws".




► For business news on the go, download ET app:

Follow ET on:

Рекомендации по теме
Комментарии
Автор

Atleast let your reporter finish what she is about to tell. Why there is so much hurry to stop your reporter to speak when she was about to tell something..

bhargabroychaudhuri
Автор

Govt is not supporting make in India covaxin

zaraf.ahmad
Автор

How much efficacy on Delta virus type of B.1.617.2 published on media

visuchary
Автор

Yes they are not accepting. Just like our beloved Prime Minister is not accepting Indian economy is at the deadlock.😄😂
Here andhbhakts are spreading the rumor that CoVaxin is more effective against Delta variants.😂🤣

sudiptoc
Автор

Why so much worry if both vaccine are effective enough? Which is slightly better doesn't matter.

Lucas-ixbg
Автор

Koi baat nahi yaar, COVISHIELD better hai to accha hi hai naa, 80-90% logo ko covishield hi lagi hogi.

ankur
Автор

Can I take after covaxin covidshield .

jaiwati
Автор

Why covaxin supply has suddenly stop ?

ranjudas
Автор

Thanks for 10 subscriber's
Ab 20 karva do
Love you all 🥰🥰😍 😘

newsmultinational